Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 4011754)

Published in PLoS One on May 06, 2014

Authors

Koji Tanaka1, Yoshinaga Okugawa1, Yuji Toiyama1, Yasuhiro Inoue1, Susumu Saigusa1, Mikio Kawamura1, Toshimitsu Araki1, Keiichi Uchida1, Yasuhiko Mohri1, Masato Kusunoki1

Author Affiliations

1: Department of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan.

Articles citing this

MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer. Int J Oncol (2016) 0.88

Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer. World J Gastroenterol (2016) 0.84

Endothelial progenitor cells and neural progenitor cells synergistically protect cerebral endothelial cells from Hypoxia/reoxygenation-induced injury via activating the PI3K/Akt pathway. Mol Brain (2016) 0.80

Upregulation of brain-derived neurotrophic factor in advanced gastric cancer contributes to bone metastatic osteolysis by inducing long pentraxin 3. Oncotarget (2016) 0.77

PI3K and MAPK pathways mediate the BDNF/TrkB-increased metastasis in neuroblastoma. Tumour Biol (2016) 0.76

Low-Intensity Extracorporeal Shock Wave Therapy Enhances Brain-Derived Neurotrophic Factor Expression through PERK/ATF4 Signaling Pathway. Int J Mol Sci (2017) 0.75

Psychoactive drugs influence brain-derived neurotrophic factor and neurotrophin 4/5 levels in the serum of colorectal cancer patients. Biomed Rep (2016) 0.75

Identification of molecular characteristics induced by radiotherapy in rectal cancer based on microarray data. Oncol Lett (2017) 0.75

Poly-L-lysine Prevents Senescence and Augments Growth in Culturing Mesenchymal Stem Cells Ex Vivo. Biomed Res Int (2016) 0.75

Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancer. J Cell Mol Med (2017) 0.75

Articles cited by this

Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature (2004) 4.53

Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev (2000) 4.07

Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg (2006) 2.62

Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature (2003) 2.26

Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer (2010) 2.13

Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proc Natl Acad Sci U S A (1997) 1.98

On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin Cancer Res (2009) 1.88

A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol (2009) 1.74

In vivo restoration of physiological levels of truncated TrkB.T1 receptor rescues neuronal cell death in a trisomic mouse model. Neuron (2006) 1.64

p75NTR--live or let die. Curr Opin Neurobiol (2005) 1.59

Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. Am J Pathol (1999) 1.37

A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival. Blood (2005) 1.35

Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Clin Cancer Res (2011) 1.30

The neurotrophic receptor TrkB: a drug target in anti-cancer therapy? Cell Mol Life Sci (2006) 1.25

Neurotrophin signaling: many exciting surprises! Cell Mol Life Sci (2006) 1.24

Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome. Cancer Lett (2009) 1.21

Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival. PLoS One (2011) 1.20

Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin Cancer Res (2003) 1.19

Endogenous truncated TrkB.T1 receptor regulates neuronal complexity and TrkB kinase receptor function in vivo. J Neurosci (2009) 1.13

Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer. Lung Cancer (2012) 1.10

Neurotrophins and their receptors in breast cancer. Cytokine Growth Factor Rev (2012) 1.05

Perifosine-induced inhibition of Akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo. Cancer (2011) 1.02

TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation. Cancer Res (2009) 1.02

Human TrkB gene: novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development. J Neurochem (2010) 1.01

Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer. Br J Cancer (2012) 1.00

Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival. Biochem Biophys Res Commun (2001) 1.00

Overexpression of p75(NTR) increases survival of breast cancer cells through p21(waf1). Cell Signal (2010) 0.99

TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma. Lung Cancer (2013) 0.96

Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades. Br J Cancer (2013) 0.96

A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma. PLoS One (2012) 0.96

Brain-derived neurotrophic factor promotes tumorigenesis via induction of neovascularization: implication in hepatocellular carcinoma. Clin Cancer Res (2011) 0.94

A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancer. Clin Colorectal Cancer (2011) 0.94

Overexpression of BDNF and TrkB in human bladder cancer specimens. Oncol Rep (2010) 0.93

High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells. J Gastroenterol (2012) 0.92

Overexpression of TrkB promotes the progression of colon cancer. APMIS (2010) 0.92

BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer. Oncology (2011) 0.90

BDNF/TrkB signaling protects HT-29 human colon cancer cells from EGFR inhibition. Biochem Biophys Res Commun (2012) 0.89

p75(NTR) induces apoptosis in medulloblastoma cells. Int J Cancer (2011) 0.88

Autocrine expression of neurotrophins and their receptors in prostate cancer. Int J Urol (2001) 0.88

Adenocarcinoma of the colon: an autopsy study with implications for new therapeutic strategies. Cancer (1985) 0.87

Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma. PLoS One (2013) 0.87

Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients. J Surg Oncol (2009) 0.86

Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma. Hum Pathol (2013) 0.84

Biological influence of brain-derived neurotrophic factor (BDNF) on colon cancer cells. Exp Ther Med (2013) 0.82

β5 integrin up-regulation in brain-derived neurotrophic factor promotes cell motility in human chondrosarcoma. PLoS One (2013) 0.81

Neurotrophic receptor, tropomyosin-related kinase B, as a chemoresistant marker in oesophageal cancer. Clin Oncol (R Coll Radiol) (2009) 0.81

Articles by these authors

Hyaluronic acid-carboxycellulose membrane (Seprafilm) reduces early postoperative small bowel obstruction in gastrointestinal surgery. Am Surg (2005) 0.90

Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis. J Surg Oncol (2009) 0.85

Late-onset peritoneal recurrence of advanced gastric cancer 20 years after primary resection. World J Surg Oncol (2010) 0.84

Angiopoietin-like Protein 2 as a Predictor of Early Recurrence in Patients After Curative Surgery for Gastric Cancer. Anticancer Res (2015) 0.76

Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach. Pediatr Blood Cancer (2015) 0.76

Identification of patients with developing ulcerative colitis-associated neoplasia by nitrative DNA damage marker 8-nitroguanin expression in rectal mucosa. J Clin Gastroenterol (2013) 0.76

Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis. Anticancer Res (2014) 0.76

Aortoduodenal syndrome in a patient receiving maintenance haemodialysis. BMJ Case Rep (2014) 0.75

Proteomics analysis of differential protein expression identifies Heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer. Int J Cancer (2016) 0.75

Dynamic pathology for leukocyte-platelet formation in sepsis model. J Surg Res (2015) 0.75

Letter to the Editor regarding the article "Congenital diaphragmatic hernia in neonates: factors related to failure of thoracoscopic repair". Pediatr Surg Int (2017) 0.75

Mesenteric lipoblastoma presenting as a small intestinal volvulus in an infant: A case report and literature review. Asian J Surg (2013) 0.75